Salim Syed
Stock Analyst at Mizuho Securities
Total Price Targets
18
Stocks Covered
12
Sectors
Healthcare
Most Recent
Dec 8, 2025
Notable Calls (Last 12 Months)
Stocks Covered by Salim Syed
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | $121.00 | $96.41 | +25.5% | 1 | Dec 8, 2025 |
| ASMB | Assembly Biosciences, Inc. | $40.00 | $27.64 | +44.7% | 2 | Nov 20, 2025 |
| WVE | Wave Life Sciences Ltd. | $19.00 | $7.32 | +159.7% | 1 | Sep 25, 2024 |
| ELVN | Enliven Therapeutics, Inc. | $39.00 | $42.00 | -7.1% | 2 | Sep 23, 2024 |
| PCVX | Vaxcyte, Inc. | $163.00 | $57.52 | +183.4% | 2 | Sep 10, 2024 |
| BBIO | BridgeBio Pharma, Inc. | $53.00 | $69.25 | -23.5% | 1 | Sep 3, 2024 |
| ATRA | Atara Biotherapeutics, Inc. | $18.00 | $4.84 | +271.9% | 1 | Aug 16, 2024 |
| GILD | Gilead Sciences, Inc. | $90.00 | $132.04 | -31.8% | 2 | Jun 17, 2024 |
| AMGN | Amgen Inc. | $235.00 | $328.69 | -28.5% | 2 | May 9, 2024 |
| CYTK | Cytokinetics, Incorporated | $99.00 | $64.40 | +53.7% | 1 | Apr 5, 2024 |
| NKTX | Nkarta, Inc. | $25.00 | $3.00 | +734.7% | 1 | Mar 22, 2024 |
| BIIB | Biogen Inc. | $270.00 | $186.69 | +44.6% | 2 | Sep 28, 2022 |
Recent Activity
- Dec 8, 2025— Set$121.00price target onINCY(Incyte Corporation)
- Nov 20, 2025— Set$40.00price target onASMB(Assembly Biosciences, Inc.)
- Sep 25, 2024— Set$19.00price target onWVE(Wave Life Sciences Ltd.)
- Sep 24, 2024— Set$36.00price target onASMB(Assembly Biosciences, Inc.)
- Sep 23, 2024— Set$39.00price target onELVN(Enliven Therapeutics, Inc.)
- Sep 10, 2024— Set$163.00price target onPCVX(Vaxcyte, Inc.)
- Sep 3, 2024— Set$53.00price target onBBIO(BridgeBio Pharma, Inc.)
- Sep 3, 2024— Set$113.00price target onPCVX(Vaxcyte, Inc.)
- Aug 16, 2024— Set$18.00price target onATRA(Atara Biotherapeutics, Inc.)
- Jun 17, 2024— Set$90.00price target onGILD(Gilead Sciences, Inc.)
- May 9, 2024— Set$235.00price target onAMGN(Amgen Inc.)
- Apr 9, 2024— Set$34.00price target onELVN(Enliven Therapeutics, Inc.)
- Apr 5, 2024— Set$99.00price target onCYTK(Cytokinetics, Incorporated)
- Mar 22, 2024— Set$25.00price target onNKTX(Nkarta, Inc.)
- Sep 28, 2022— Set$270.00price target onBIIB(Biogen Inc.)
- May 10, 2022— Set$208.00price target onAMGN(Amgen Inc.)
- Feb 8, 2022— Set$75.00price target onGILD(Gilead Sciences, Inc.)
- Feb 7, 2022— Set$207.00price target onBIIB(Biogen Inc.)
Frequently Asked Questions
Who is Salim Syed?
Salim Syed is a stock analyst at Mizuho Securities covering 12 stocks primarily in Healthcare. They have issued 18 price targets since Feb 7, 2022.
What stocks does Salim Syed cover?
Salim Syed currently covers 12 stocks, including ASMB, ELVN, PCVX, GILD, AMGN.
What is Salim Syed's latest price target?
Salim Syed's most recent price target was $121.00 on INCY (Incyte Corporation), set on Dec 8, 2025.
What is Salim Syed's highest price target?
Salim Syed's highest issued price target is $270.00 on BIIB, set on Sep 28, 2022.
More Analysts at Mizuho Securities
Coverage based on publicly published price targets. Not investment advice.